Showing results (161-170 of 191) with videos related to
Sort By:
Pageof 20
The Prostate|July 21, 2004
Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOFM B Gretzer, D W Chan, C L van Rootselaar, et al.The Journal of Urology|April 1, 1988
Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomyJ E Oesterling, D W Chan, J I Epstein, et al.The Journal of Pathology|May 9, 2008
Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesisD W Chan, S Y M Yu, P M Chiu, et al.The Prostate. Supplement|January 1, 1996
Clearance rate of serum-free and total PSA following radical retropubic prostatectomyA W Partin, S Piantadosi, E N Subong, et al.Clinical Chemistry|November 1, 1983
Clinical evaluation of two direct procedures for free thyroxin, and of free thyroxin index determined nonisotopically and by measuring thyroxin-binding globulinJ M Waud, D W Chan, H M Drew, et al.Urology|December 31, 1997
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancerJ Pannek, H G Rittenhouse, C L Evans, et al.Urology|December 1, 1996
The role of free/total prostate-specific antigen ratio in the prediction of final pathologic stage for men with clinically localized prostate cancerJ Pannek, E N Subong, K A Jones, et al.Anticancer Research|September 2, 1999
Multicenter evaluation of the Elecsys CA 125 II assayW Hubl, D W Chan, H E Van Ingen, et al.Prostate Cancer and Prostatic Diseases|December 24, 2002
Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancerA W Partin, M K Brawer, E N P Subong, et al.Cancer Research|June 15, 1992
Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate diseaseH B Carter, C H Morrell, J D Pearson, et al.Pageof 20